Cramer’s lightning round: Vir and GlaxoSmithKline 'may have something' that could fight omicron

Deutschland Nachrichten Nachrichten

Cramer’s lightning round: Vir and GlaxoSmithKline 'may have something' that could fight omicron
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 CNBC
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

“Mad Money” host Jim Cramer rings the lightning round bell on Vir Biotechnology, Enbridge, On Semiconductor and Robinhood.

Enbridge

: "That stock has just been in a house of pain. However, it does yield 7%. That's [CEO] Al Monaco. They've got a great long term business. I don't understand why it's going down, other than being brought down by the fact that oil suddenly went from $80 to $70 to $64. Buy Enbridge.": "We've had [CEO] Hassane El-Khoury on multiple times. I think he's a genius. He put together Cypress with this. He's got the best automobile chips.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

CNBC /  🏆 12. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Vir Biotechnology, Digital World Acquisition, Apple: What to Watch in the Stock Market TodayVir Biotechnology, Digital World Acquisition, Apple: What to Watch in the Stock Market TodayApple shares are slipping ahead of the open; Vir Biotechnology said its Covid-19 treatment had been successful in a study
Weiterlesen »

COVID-19 Antibody Drug Likely Works Against Omicron, Companies SayCOVID-19 Antibody Drug Likely Works Against Omicron, Companies SayEarly lab studies show that a COVID-19 antibody treatment developed by GlaxoSmithKline and Vir Biotechnology could be effective against the Omicron variant.
Weiterlesen »

What Jim Cramer is watching in the market Thursday, including Apple and BoeingWhat Jim Cramer is watching in the market Thursday, including Apple and BoeingInvesting Club: What Jim Cramer is watching in the market Thursday, including Apple and Boeing
Weiterlesen »

GSK says tests indicate antibody drug works against OmicronGSK says tests indicate antibody drug works against OmicronLaboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday.
Weiterlesen »

Oil rises on views OPEC+ may pause supply addition amid Omicron fearsOil rises on views OPEC+ may pause supply addition amid Omicron fearsOil prices rose on Thursday, reversing the previous day's losses, on expectations OPEC+ may pause supply additions amid growing concern the spread of the Omicron coronavirus variant could weigh on the global economy and fuel demand.
Weiterlesen »



Render Time: 2025-03-13 15:01:39